BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26177421)

  • 1. Is Minocycline an Antiviral Agent? A Review of Current Literature.
    Nagarakanti S; Bishburg E
    Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):4-8. PubMed ID: 26177421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of minocycline in viral infections.
    Dutta K; Basu A
    Indian J Med Res; 2011 May; 133(5):467-70. PubMed ID: 21623029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is behind the non-antibiotic properties of minocycline?
    Garrido-Mesa N; Zarzuelo A; Gálvez J
    Pharmacol Res; 2013 Jan; 67(1):18-30. PubMed ID: 23085382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minocycline: far beyond an antibiotic.
    Garrido-Mesa N; Zarzuelo A; Gálvez J
    Br J Pharmacol; 2013 May; 169(2):337-52. PubMed ID: 23441623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minocycline in acne vulgaris: benefits and risks.
    Ochsendorf F
    Am J Clin Dermatol; 2010; 11(5):327-41. PubMed ID: 20642295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis.
    Mishra MK; Basu A
    J Neurochem; 2008 Jun; 105(5):1582-95. PubMed ID: 18208541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minocycline: a bacteriostatic antibiotic with pleiotropic cardioprotective effects.
    Brenes-Salazar JA
    Can J Physiol Pharmacol; 2015 Oct; 93(10):863-6. PubMed ID: 26382908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is minocycline useful for therapy of acute viral encephalitis?
    Jackson AC
    Antiviral Res; 2012 Sep; 95(3):242-4. PubMed ID: 22728256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing the role of tigecycline in an era of antimicrobial resistance.
    Schafer JJ; Goff DA
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):557-67. PubMed ID: 18847395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and risks of minocycline in rheumatoid arthritis.
    Langevitz P; Livneh A; Bank I; Pras M
    Drug Saf; 2000 May; 22(5):405-14. PubMed ID: 10830256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-apoptotic and anti-oxidative mechanisms of minocycline against sphingomyelinase/ceramide neurotoxicity: implication in Alzheimer's disease and cerebral ischemia.
    Chen SD; Yin JH; Hwang CS; Tang CM; Yang DI
    Free Radic Res; 2012 Aug; 46(8):940-50. PubMed ID: 22583533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Minocycline].
    Bernier C; Dréno B
    Ann Dermatol Venereol; 2001 May; 128(5):627-37. PubMed ID: 11427798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline vs tetracycline.
    Shubin JA
    J Fam Pract; 1995 Dec; 41(6):538. PubMed ID: 7500059
    [No Abstract]   [Full Text] [Related]  

  • 14. Minocycline for patients with ALS.
    Carrì MT
    Lancet Neurol; 2008 Feb; 7(2):118-9; author reply 120-1. PubMed ID: 18207105
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of minocycline in ischemia-reperfusion injury: a comprehensive review of an old drug with new implications.
    Ulgen BO; Field MG; Qureshi W; Knight RA; Stephanou A; Latchman DS; Vasquez D; Barry SP; Saravolatz L; Scarabelli GM; Faggian G; Mazzucco A; Saravolatz L; Chen-Scarabelli C; Scarabelli TM
    Recent Pat Cardiovasc Drug Discov; 2011 May; 6(2):123-32. PubMed ID: 21599619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minocycline.
    Jonas M; Cunha BA
    Ther Drug Monit; 1982; 4(2):137-45. PubMed ID: 7048646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline administered intravenously: pharmacological activity and clinical experience.
    Clark BJ; Hodgson CR; Dornbush AC; Hutchinson J
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):865-77. PubMed ID: 4214661
    [No Abstract]   [Full Text] [Related]  

  • 18. Moroxydine: the story of a mislaid antiviral.
    Sheppard S
    Acta Derm Venereol Suppl (Stockh); 1994; 183():1-9. PubMed ID: 9868507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin, minocycline and ascorbic acid reduce oxidative stress and viral titers and increase survival rate in experimental Venezuelan equine encephalitis.
    Valero N; Mosquera J; Alcocer S; Bonilla E; Salazar J; Álvarez-Mon M
    Brain Res; 2015 Oct; 1622():368-76. PubMed ID: 26168898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline: a neuroprotective agent for hypoxic-ischemic brain injury in the neonate?
    Buller KM; Carty ML; Reinebrant HE; Wixey JA
    J Neurosci Res; 2009 Feb; 87(3):599-608. PubMed ID: 18831005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.